CD274 and lung adenocarcinoma: A total of 463 lung adenocarcinoma samples were screened for eligibility; 78 patients were excluded due to insufficient data and/or tissue to determine the prespecified clinical and histological variables; 145 were excluded because IHC staining for PD-L1 was performed using a different antibody (SP263).